Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Acq. announced
ANI PHARMACEUTICALS INC (ANIP) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
05/08/2023 8-K Quarterly results
Docs: "ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance"
03/09/2023 8-K Quarterly results
Docs: "ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance"
11/09/2022 8-K Quarterly results
11/09/2022 8-K Quarterly results
08/08/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
03/15/2022 8-K Quarterly results
Docs: "ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; Strong Foundation in Place to Drive Sustainable Growth"
11/01/2021 8-K Quarterly results
Docs: "ANI Pharmaceuticals Reports Third Quarter 2021 Results"
08/06/2021 8-K Quarterly results
Docs: "ANI Pharmaceuticals Reports Second Quarter 2021 Results"
05/07/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "ANI Pharmaceuticals Reports Third Quarter 2020 Results"
08/06/2020 8-K Quarterly results
05/07/2020 8-K Quarterly results
02/27/2020 8-K Quarterly results
11/06/2019 8-K Quarterly results
05/09/2019 8-K Quarterly results
Docs: "For the first quarter 2019: Net revenues of $52.9 million, an increase of 14% versus 2018 GAAP net income of $0.4 million and diluted GAAP earnings per share of $0.04 Record adjusted non-GAAP EBITDA of $22.3 million"
02/27/2019 8-K Quarterly results
11/06/2018 8-K Quarterly results
Docs: "For the third quarter 2018: Record net revenues of $50.7 million, an increase of 5% as compared to the same period in 2017 GAAP net income of $5.0 million and diluted GAAP earnings per share of $0.42 Adjusted non-GAAP EBITDA of $21.4 million"
05/08/2018 8-K Quarterly results
Docs: "For the first quarter 2018: Net revenues of $46.5 million, an increase of 27% as compared to the same period in 2017 GAAP net income of $2.3 million and diluted GAAP earnings per share of $0.19 Adjusted non-GAAP EBITDA of $21.8 million"
02/27/2018 8-K Quarterly results
Docs: "For the full year ended December 31, 2017: Record net revenues of $176.8 million, an increase of 37% versus 2016 GAAP net loss of $1.1 million, including a $13.4 million charge due to the Tax Cuts and Jobs Act Diluted GAAP loss per share of $0.09, including $1.16 impact of charge due to the Tax Cuts and Jobs Act Adjusted non-GAAP EBITDA of $74.2 million Adjusted non-GAAP diluted earnings per share of $3.91 For the fourth quarter 2017: Net revenues of $47.3 million, an increase of 24% as compared to the same period in 2016 GAAP net loss of $9.6 million, including impact of $13.4 million charge due to the Tax Cuts and Jobs Act Diluted GAAP loss per share of $0.83, including $1.16 impact of charge due to the Tax Cuts and Jobs Act Adjusted non-GAAP EBITDA of $19.7 million Adjusted non-GAAP dil..."
05/04/2017 8-K Form 8-K - Current report
03/02/2017 8-K Form 8-K - Current report
11/03/2016 8-K Form 8-K - Current report
08/04/2016 8-K Form 8-K - Current report
05/05/2016 8-K Form 8-K - Current report
02/23/2016 8-K Quarterly results
Docs: "Exhibit 99.1 ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Results and Provides 2016 Guidance"
11/03/2015 8-K Quarterly results
Docs: "ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2015 Results and Highlights"
05/05/2015 8-K Quarterly results
Docs: "ANI Pharmaceuticals Reports First Quarter 2015 Financial Results"
02/19/2015 8-K Quarterly results
Docs: "ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2014 Financial Results"
11/03/2014 8-K Quarterly results
Docs: "ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights"
08/04/2014 8-K Quarterly results
Docs: "ANI Reports Second Quarter 2014 Financial Results and Year-To-Date Highlights"
05/05/2014 8-K Quarterly results
Docs: "ANI Pharmaceuticals Reports Record Net Revenues of $10.9 million, EPS of $0.33, and Adjusted Non-GAAP EBITDA of $4.2 Million for the First Quarter Ended March 31, 2014"
02/18/2014 8-K Quarterly results
Docs: "ANI Pharmaceuticals Reports Record Net Revenues of $10.5 million, EPS from continuing operations of $0.35, and Adjusted Non-GAAP EBITDA of $3.9 Million for the Fourth Quarter Ended December 31, 2013"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy